YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Novo Nordisk is cutting direct-to-consumer prices for weight loss drug Wegovy and diabetes counterpart Ozempic, CNBC reports.
The price of the drugs is dropping to $349 per month from $499 per month for existing cash-paying patients. The highest dose of Ozempic will remain at $499 per month.
Novo Nordisk also is launching a temporary introductory offer for the drugs. Patients can receive the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects